Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.

MLA

Jiménez-Cortegana, Carlos, et al. “Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.” Frontiers in Immunology, vol. 12, Jan. 2022, p. 801410. EBSCOhost, https://doi.org/10.3389/fimmu.2021.801410.

APA

Jiménez-Cortegana, C., Sánchez-Jiménez, F., Pérez-Pérez, A., Álvarez, N., Sousa, A., Cantón-Bulnes, L., Vilariño-García, T., Fuentes, S., Martín, S., Jiménez, M., León-Justel, A., de la Cruz-Merino, L., Garnacho-Montero, J., & Sánchez-Margalet, V. (2022). Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19. Frontiers in Immunology, 12, 801410. https://doi.org/10.3389/fimmu.2021.801410

Chicago

Jiménez-Cortegana, Carlos, Flora Sánchez-Jiménez, Antonio Pérez-Pérez, Nerissa Álvarez, Alberto Sousa, Luisa Cantón-Bulnes, Teresa Vilariño-García, et al. 2022. “Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.” Frontiers in Immunology 12 (January): 801410. doi:10.3389/fimmu.2021.801410.